Hew Health Field Notes
Dispatch 04 August 2026 5 min read

Regenerative Post-Surgical Wound Care for Active Patients

Regenerative Approaches to Post-Surgical Wound Care: Supporting Recovery in Active Patients Recovery from surgery has a rhythm most active patients find frustrating. You feel ready to move at week three, but the tissue underneath is still knitting itself together at its own pace. In our practice, we spend a lot

Regenerative Post-Surgical Wound Care for Active Patients
Field Notes · Vol. I 04.08.2026
Regenerative Post-Surgical Wound Care for Active Patients

Regenerative Approaches to Post-Surgical Wound Care: Supporting Recovery in Active Patients

Recovery from surgery has a rhythm most active patients find frustrating. You feel ready to move at week three, but the tissue underneath is still knitting itself together at its own pace. In our practice, we spend a lot of time managing that gap between what patients want to do and what their biology will actually tolerate. Regenerative approaches to wound care are one of the tools we use to narrow that gap, particularly for people whose baseline expectations for their own body are high.

What follows is a practical look at how we think about supporting post-surgical healing in athletes, weekend warriors, and anyone whose work or life demands more than a passive recuperation. This is not a survey of every option on the market. It is how we approach the problem in a concierge setting where we know the patient well and can adjust the plan week by week.

Why Post-Surgical Wounds Behave Differently in Active Patients

Surgical wounds heal in overlapping phases: hemostasis, inflammation, proliferation, and remodeling. That last phase can run twelve to eighteen months. Most patients feel functionally recovered long before the tissue reaches its final tensile strength. In an active person, this mismatch matters. The collagen that fills a rotator cuff repair or an abdominal fascia closure at week six is disorganized and weaker than what was there before. Return to load too quickly and you get dehiscence, chronic inflammation, or a repair that heals in an elongated position.

Active patients also present some specific challenges we watch for. They often run lean, which sounds healthy but can mean lower protein reserves for tissue building. They tend to under-eat during the early recovery window because appetite drops and they are not training. Many are on NSAIDs longer than they should be. Some have subclinical iron or vitamin D deficiencies that never mattered until their body was asked to build new tissue on demand.

The Foundation: Getting the Basics Right Before Anything Fancy

Regenerative therapies do not rescue a poorly managed recovery. Before we discuss anything advanced, we look hard at the fundamentals with each patient.

Protein intake is the one I raise first. Most active patients think they eat enough protein. Post-surgery, we want roughly 1.6 to 2.2 grams per kilogram of body weight per day, distributed across meals. For a 75 kg patient, that is 120 to 165 grams daily, which is more than most people hit without deliberate effort during a period when they are not hungry.

Sleep is the second. Growth hormone pulses during slow-wave sleep drive much of the reparative work. Patients on opioids often have fragmented sleep architecture even when they think they slept eight hours. We taper narcotics as aggressively as pain allows and look at magnesium, sleep timing, and light exposure to protect the deeper stages.

Then we check the lab work that actually influences healing: ferritin, vitamin D, B12, albumin, HbA1c, and a full thyroid panel. A patient with a ferritin of 22 and a vitamin D of 19 will heal, but not the way they could. We correct these deliberately, not with a shotgun supplement approach.

Where Regenerative Therapies Fit

Once the foundation is solid, there are several regenerative options we consider for post-surgical wound care and orthopedic recovery. The choice depends on the surgery, the tissue involved, timing, and the patient's specific goals.

Platelet-Rich Plasma (PRP)

PRP uses a concentrated fraction of the patient's own platelets, delivered to a healing site to increase local growth factor concentrations. In post-surgical orthopedic contexts, we most often see it used after rotator cuff repair, Achilles work, ACL reconstruction, and certain tendon procedures. The evidence base varies by application, and the preparation method matters enormously. Leukocyte-rich versus leukocyte-poor PRP behave differently in tendon versus joint environments. This is not a commodity service, and I am skeptical of clinics that treat it as one.

Peptide Protocols for Tissue Support

Several peptides are used as protocols to support the healing environment after orthopedic surgery and in wound care and pain management contexts. BPC-157 and TB-500 are the two most commonly discussed. These are used as adjuncts, not as substitutes for surgical technique, physical therapy, or nutrition. We are careful with candidate selection, dosing, and duration, and we document what we see clinically.

Peptide protocols are not appropriate for every patient. A history of certain cancers, active infection, or specific medication interactions can change the calculus. This is a conversation, not a menu item.

Growth Factor and Cytokine-Based Wound Care

For surgical wounds that are slow to close, particularly in patients with any degree of vascular compromise, diabetes, or a history of poor healing, we work with topical growth factor preparations and advanced dressings. The goal here is straightforward: keep the wound bed clean, moist, appropriately oxygenated, and biochemically supportive of epithelial migration. This is old-school wound care done well, with newer tools where they add something meaningful.

Timing Matters More Than People Realize

One of the most common questions we get is when to introduce regenerative therapies relative to surgery. There is no single answer, but a few principles hold.

Very early inflammation is not the enemy. It is the signal that recruits the cells doing the repair work. Suppressing it aggressively, whether with NSAIDs or with regenerative interventions applied too early, can blunt the exact process you want to support. We generally let the acute inflammatory phase run its course, then look at where the patient is at two to four weeks and decide whether adjunctive support makes sense.

For elective orthopedic procedures, we sometimes work with patients before surgery to optimize the terrain: correcting deficiencies, improving sleep, building a small protein and micronutrient reserve, and getting the tissue as strong as it can be at the start. Prehabilitation is undervalued, and it is one of the areas where concierge care shows its worth. You have time to actually do it.

What Return to Activity Should Look Like

The framework we use is tissue-specific, not calendar-specific. A patient six weeks out from a meniscal repair is not the same as a patient six weeks out from an inguinal hernia. We stage load based on the tissue's known healing timeline, the patient's response to progressive challenge, and objective markers where we have them (strength testing, range of motion, imaging when indicated).

The patients who do best share a few habits. They communicate early when something feels off. They resist the temptation to test their limits in weeks four through eight, which is when tissue feels much stronger than it actually is. They treat the boring middle phase of recovery as its own training block, with the same attention they would give to a season.

A Note on What Regenerative Medicine Is Not

Regenerative therapies are tools, used within specific clinical contexts, with realistic expectations. In our practice, we use them for orthopedic recovery, wound care, and pain management. We do not present them as cures or guaranteed outcomes, and we do not use them outside of these applications. When a patient asks about something we cannot support, we say so.

The value of a concierge relationship in this space is having a clinician who knows your history, your training, your goals, and your labs, and who can tell you honestly what will and will not help. Recovery from a significant surgery is not a place for guesswork.

Regenerative therapies discussed in this article are not FDA-approved for these uses and are offered pursuant to Fla. Stat. § 458.3245. Individual candidacy is determined through clinical evaluation.

If you have a procedure on the calendar, or you are working through a recovery that is not going the way you expected, request a consultation with our team to talk through what a supported plan could look like for you.


Related from Hew Health